Evidence map›Paper›PMID 39567685›Full record

ArticleNature2024

Broadly inhibitory antibodies to severe malaria virulence proteins.

Raphael A Reyes, Sai Sundar Rajan Raghavan, Nicholas K Hurlburt, Viola Introini, Sebastiaan Bol, Ikhlaq Hussain Kana, Rasmus W Jensen, Elizabeth Martinez-Scholze, María Gestal-Mato, Borja López-Gutiérrez and 19 more

Abstract read
In one paragraph

Article in Nature, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Febrile temperature enhancesbioRxiv : the preprint server for biology · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Malaria monoclonals block brain binding.Trends in parasitology · 2025
    Article
  15. Review
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors.

Raphael A Reyes *Department of Microbiology, Immunology and Molecular Genetics, Long School of Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.ORCID 0000-0002-2234-4758
Sai Sundar Rajan Raghavan *Centre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, University of Copenhagen and Department of Infectious Diseases, Righospitalet, Copenhagen, Denmark.ORCID 0000-0002-2575-2685
Nicholas K Hurlburt *Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.ORCID 0000-0001-9891-916X
Viola Introini *EMBL Barcelona, Barcelona, Spain.ORCID 0000-0001-9012-4696
Sebastiaan BolDepartment of Microbiology, Immunology and Molecular Genetics, Long School of Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.ORCID 0000-0002-3843-6657
Ikhlaq Hussain KanaCentre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, University of Copenhagen and Department of Infectious Diseases, Righospitalet, Copenhagen, Denmark.
Rasmus W JensenCentre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, University of Copenhagen and Department of Infectious Diseases, Righospitalet, Copenhagen, Denmark.
Elizabeth Martinez-ScholzeDepartment of Microbiology, Immunology and Molecular Genetics, Long School of Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
María Gestal-MatoEMBL Barcelona, Barcelona, Spain.ORCID 0000-0002-5096-2609
Borja López-GutiérrezEMBL Barcelona, Barcelona, Spain.ORCID 0000-0002-7159-5836
Silvia SanzEMBL Barcelona, Barcelona, Spain.ORCID 0000-0003-4334-3284
Cristina BancellsEMBL Barcelona, Barcelona, Spain.
Monica Lisa Fernández-QuinteroDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.ORCID 0000-0002-6811-6283
Johannes R LoefflerDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
James Alexander FergusonDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
Wen-Hsin LeeDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.ORCID 0000-0001-9445-6671
Greg Michael MartinDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
Thor G TheanderCentre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, University of Copenhagen and Department of Infectious Diseases, Righospitalet, Copenhagen, Denmark.
John P A LusinguNational Institute for Medical Research, Tanga Research Centre, Tanga, Tanzania.
Daniel T R MinjaNational Institute for Medical Research, Tanga Research Centre, Tanga, Tanzania.
Isaac SsewanyanaInfectious Disease Research Collaboration, Kampala, Uganda.
Margaret E FeeneyDepartment of Medicine, University of California San Francisco, San Francisco, CA, USA.ORCID 0000-0002-2515-2989
Bryan GreenhouseDepartment of Medicine, University of California San Francisco, San Francisco, CA, USA.
Andrew B WardDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.ORCID 0000-0001-7153-3769
Maria BernabeuEMBL Barcelona, Barcelona, Spain.ORCID 0000-0001-7212-6209
Marie PanceraVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.ORCID 0000-0001-9217-6270
Louise TurnerCentre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, University of Copenhagen and Department of Infectious Diseases, Righospitalet, Copenhagen, Denmark. lturner@sund.ku.dk.ORCID 0000-0003-4494-2289
Evelien M BunnikDepartment of Microbiology, Immunology and Molecular Genetics, Long School of Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA. bunnik@uthscsa.edu.ORCID 0000-0003-4003-3053
Thomas LavstsenCentre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, University of Copenhagen and Department of Infectious Diseases, Righospitalet, Copenhagen, Denmark. thomasl@sund.ku.dk.ORCID 0000-0002-3044-4249

Funding

TISSUE CULTURE---COREP30CA054174 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Robin Jean Leach · 1991 to 2026
$59.1M
Transmission ProjectU19AI089674 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Joaniter Immaculate Nankabirwa · 2010 to 2026
$29.3M
The role of γδ T cells in fetal and infant immune defense against malariaR01AI093615 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FEENEY, MARGARET E · 2011 to 2025
$9.1M
Computational models of naturally acquired immunity to falciparum malariaU01AI150741 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BUTTE, ATUL J, GREENHOUSE, BRYAN R · 2020 to 2024
$7.4M
Defining conserved epitopes on polymorphic malaria antigensR01AI153425 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI BUNNIK, EVELIEN MARGARETHA · 2021 to 2025
$2.7M
NRSA Training Core (TL1)TL1TR002647 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CHUN, YONG-HEE PATRICIA, FREI, CHRISTOPHER R. · 2018 to 2022
$1.8M
Acquisition of a Rigaku XtaLAB Synergy-R macromolecular diffraction instrumentation at Fred Hutchinson Cancer Research CenterS10OD028581 · OD · FRED HUTCHINSON CANCER RESEARCH CENTER · PI STODDARD, BARRY L. · 2020 to 2020
$600k
FACSAria Fusion cell sorter for Flow Cytometry Shared ResourceS10OD030432 · OD · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI BERTON, MICHAEL T · 2022 to 2022
$596k
Molecular and cellular properties of broad and protective immune responses to the Plasmodium falciparum variant surface antigen responsible for severe malariaF31AI169993 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI REYES, RAPHAEL ANTHONY · 2022 to 2023
$46k
European Molecular Biology LaboratoryNCATS NIH HHS TL1 TR002647NCI NIH HHS P30 CA054174NIAID NIH HHS F31 AI169993NIAID NIH HHS R01 AI093615NIAID NIH HHS R01 AI153425NIAID NIH HHS U01 AI150741NIAID NIH HHS U19 AI089674NIH HHS S10 OD028581NIH HHS S10 OD030432Wellcome Trust
6 · The paper itself

Abstract

Malaria pathology is driven by the accumulation of Plasmodium falciparum-infected erythrocytes in microvessels

Indexed as

Antibodies, ProtozoanBroadly Neutralizing AntibodiesMalaria, FalciparumPlasmodium falciparumProtozoan ProteinsVirulenceVirulence FactorsAnimalsAntibodies, MonoclonalBinding SitesBrainEndothelial Protein C ReceptorErythrocytesHumansMalaria VaccinesMicrovesselsAntibodies, MonoclonalAntibodies, ProtozoanBroadly Neutralizing AntibodiesEndothelial Protein C Receptorerythrocyte membrane protein 1, Plasmodium falciparumMalaria VaccinesPROCR protein, humanProtozoan ProteinsVirulence Factors

Identifiers

PMID39567685
PMCPMC12338075

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.